Ruijin Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Ruijin Hospital appears in 180 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials180

Recruiting shown34

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's DiseaseNCT07774312 · lead sponsor · 2026-07-27

Directional PSA Versus STN DBS for TD-PDNCT07700862 · lead sponsor · 2026-07-01

BCI With 40Hz Stimulation in Alzheimer's DiseaseNCT07618481 · lead sponsor · 2026-05-01

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast CancerNCT07527689 · lead sponsor · 2026-04-22

Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass NodulesNCT07232433 · lead sponsor · 2025-11-21

Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's DiseaseNCT07157345 · lead sponsor · 2025-10-20

Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary IrradiationNCT07498855 · lead sponsor · 2025-10-01

SEEG-Guided DBS for SchizophreniaNCT07671261 · lead sponsor · 2025-08-17

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%NCT07115992 · lead sponsor · 2025-07-30

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)NCT07353463 · lead sponsor · 2025-04-01

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application StudyNCT06946953 · lead sponsor · 2025-03-23

Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and HypertensionNCT06829134 · lead sponsor · 2025-03-01

68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLCNCT06756217 · lead sponsor · 2024-12-30

A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesNCT06567353 · lead sponsor · 2024-12-09

Safety and Efficacy of IMPT or IMRT for Breast CancerNCT06826885 · lead sponsor · 2024-12-01

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung CancerNCT06623487 · lead sponsor · 2024-07-19

Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer PatientsNCT06404697 · lead sponsor · 2024-05-01

Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive ExpressionNCT06269211 · lead sponsor · 2024-04-20

Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction TreatmentNCT06534489 · lead sponsor · 2023-08-31

Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)NCT06009718 · lead sponsor · 2023-08-25

Regional Lymph Node Irradiation for High-risk pN0 Breast CancerNCT05976412 · lead sponsor · 2023-07-28

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialNCT06114225 · lead sponsor · 2023-06-01

Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's DiseaseNCT05887674 · lead sponsor · 2023-05-11

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung CancerNCT04973293 · lead sponsor · 2022-10-01

Shanghai At Risk for Alzheimer's Disease: a Cohort StudyNCT05597410 · lead sponsor · 2022-03-01

Ruijin Neurobank of Alzheimer's Disease and DementiaNCT05623124 · lead sponsor · 2021-11-22

Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast CancerNCT04517266 · lead sponsor · 2021-03-01

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapyNCT05552846 · lead sponsor · 2021-01-30

Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative DementiaNCT06534658 · lead sponsor · 2020-07-30

Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard TreatmentNCT03829553 · lead sponsor · 2019-02-21

Study of High Efficient Killing Cell Therapy for Advanced NSCLCNCT03193567 · lead sponsor · 2017-09-14

Risk Evaluation and Management in Heart FailureNCT02998788 · lead sponsor · 2016-06-01

Metabolic Abnormalities, Lifestyle and Diet Pattern in Heart FailureNCT03951311 · lead sponsor · 2016-06-01

Cardiometabolic evalUation REgistry of Heart FailureNCT06939985 · lead sponsor · 2015-01-01

Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic CancerNCT07745790 · lead sponsor · 2026-07-13

NOT_YET_RECRUITING

Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target ExplorationNCT07698236 · lead sponsor · 2026-07-03

ENROLLING_BY_INVITATION

Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot StudyNCT07664787 · lead sponsor · 2026-07-01

NOT_YET_RECRUITING

Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast CancerNCT07543107 · lead sponsor · 2026-04-16

NOT_YET_RECRUITING

Proton vs Photon IMRT Toxicity in Breast CancerNCT07537712 · lead sponsor · 2026-04-01

NOT_YET_RECRUITING

Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's DiseaseNCT07543094 · lead sponsor · 2025-11-01

ENROLLING_BY_INVITATION

Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's DiseaseNCT07151157 · lead sponsor · 2025-08-30

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.NCT07184697 · lead sponsor · 2025-08-14

ACTIVE_NOT_RECRUITING

The Efficacy and Safety of Puerarin in Obesity TreatmentNCT06968208 · lead sponsor · 2025-08-01

NOT_YET_RECRUITING

A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's DiseaseNCT07085195 · lead sponsor · 2025-08-01

NOT_YET_RECRUITING

Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABGNCT06730945 · lead sponsor · 2025-06-01

6 Weeks Right-Amygdala TIS for DepressionNCT07059143 · lead sponsor · 2025-05-27

Intrapatient Comparison of STN and GPi tTIS in PDNCT07018388 · lead sponsor · 2025-04-23

ENROLLING_BY_INVITATION

STN-tTIS Modulates Parkinson Motor Symptoms With and Without MedicationsNCT06980935 · lead sponsor · 2025-04-14

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy PatientsNCT06738862 · lead sponsor · 2024-12-14

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell TransplantationNCT06704542 · lead sponsor · 2024-11-01

NOT_YET_RECRUITING

The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis PatientsNCT06697418 · lead sponsor · 2024-10-01

ENROLLING_BY_INVITATION

Precision Regional Node Irradiation for Sentinel Node-positive Breast CancerNCT06583655 · lead sponsor · 2024-10-01

ACTIVE_NOT_RECRUITING

First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart FailureNCT06621576 · lead sponsor · 2024-09-18

Amygdala TIS for DepressionNCT06477276 · lead sponsor · 2024-07-24

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.NCT06608160 · lead sponsor · 2024-06-20

Cognitive Impairment Cohort Study of the Elderly Population in YuGardenNCT06325527 · lead sponsor · 2024-04-01

NOT_YET_RECRUITING

PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary LesionsNCT06602674 · lead sponsor · 2024-04-01

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's DiseaseNCT07034222 · lead sponsor · 2024-02-01

ACTIVE_NOT_RECRUITING

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image FeaturesNCT06604377 · lead sponsor · 2023-11-01

Remote Programming for Deep Brain Stimulation in Parkinson's Disease.NCT06078397 · lead sponsor · 2023-10-30

Drugs studied in this sponsor's trials

25 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Ruijin Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo3

amlodipine2

docetaxel2

gefitinib2

trastuzumab2

anastrozole1

atenolol1

bevacizumab1

placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials amlodipine RxCUI 17767 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials docetaxel RxCUI 72962 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials gefitinib RxCUI 328134 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials trastuzumab RxCUI 224905 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials anastrozole RxCUI 84857 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atenolol RxCUI 1202 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bevacizumab RxCUI 253337 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial bisoprolol RxCUI 19484 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial clozapine RxCUI 2626 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial entecavir RxCUI 306266 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial entrectinib RxCUI 2197862 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial epirubicin RxCUI 3995 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fosinopril RxCUI 50166 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Herceptin RxCUI 101306 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial hydrochlorothiazide RxCUI 5487 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial irbesartan RxCUI 83818 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial iron sucrose Injection RxCUI 1741260 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paclitaxel protein-bound RxCUI 486610 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ranibizumab RxCUI 595060 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ranibizumab Injection [Lucentis] RxCUI 1724213 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor126

collaborator54

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.